Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
The classification of Intranasal Drug Delivery Devices includes Multidose and Uni/bidose, and the proportion of Multidose in 2017 is about 85%, and the proportion is in decreasing trend from 2013 to 2017.
North America, especially The United States, will still play an important role which cannot be ignored, with market size of 340 million USD in 2017 and will be 770 million USD in 2025. Any changes from United States might affect the development trend of Intranasal Drug Delivery Devices. North America region is the largest consumer of Intranasal Drug Delivery Devices, with a market share nearly 43% in 2017.
Europe also plays important roles in global market, with market size of 270 million USD in 2017, enjoying sales market share nearly 34% in 2017.The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
The report offers detailed coverage of Intranasal Drug Delivery Devices industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Intranasal Drug Delivery Devices by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Intranasal Drug Delivery Devices market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Intranasal Drug Delivery Devices market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
BD
AptarGroup
3M
Teleflex
H&T Presspart
Bespak
At the same time, we classify Intranasal Drug Delivery Devices according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Multidose
Uni/bidose
Market by Application
Personal Use
Hospital Use
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Intranasal Drug Delivery Devices market for the forecast period 2021 - 2025?
• What are the driving forces in the Intranasal Drug Delivery Devices market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Intranasal Drug Delivery Devices industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?